Clinical Trial Update: Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy [Phase 3]

View source ↗

Summary

Belite Bio reports a Phase 3 randomized, placebo-controlled trial to evaluate the safety and efficacy of Tinlarebant in geographic atrophy, which is currently a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Geographic Atrophy

Drugs mentioned

• Tinlarebant

Snippet

Sponsor: Belite Bio, Inc | Conditions: Geographic Atrophy | Phase 3 | Status: ACTIVE_NOT_RECRUITING